Objective: To investigate clinical, hormonal, and ultrasound characteristics in women with breast fibroadenoma and assess the role of endocrine disorders in its pathogenesis.
Materials and Methods: Eighty-four women aged 18–45 years (mean 32.6 ± 6.7) with breast fibroadenoma were examined. Assessments included anamnesis, clinical and anthropometric evaluation, ultrasound of pelvic organs, breasts, thyroid gland, and hormonal profile (FSH, LH, prolactin, TSH, free T3/T4, estradiol, progesterone, free testosterone).
Results: Menstrual disorders occurred in 60 (71.4%) patients, mainly oligomenorrhea/opsomenorrhea — 32 (53.3%) and chronic anovulation — 20 (33.3%). Infertility was present in 17 (40.4%), mean duration 4.01 ± 0.18 years. Metabolic disturbances affected 71.3% of participants. Ultrasound abnormalities included endometriosis (38%), uterine myoma (21.4%), follicular cysts (31%), and polycystic ovaries (10.8%). Hormonal disorders were dominated by thyroid hypofunction (46.7%) and hyperprolactinemia (23.8%). Estradiol and progesterone were within reference ranges in most cases.
Conclusion: Breast fibroadenoma in reproductive-age women is associated with complex hormonal imbalance, particularly thyroid dysfunction and hyperprolactinemia, rather than isolated hyperestrogenism, underscoring the need for comprehensive endocrine evaluation and targeted management.